These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8765195)

  • 21. Expression of basic fibroblast growth factor and its mRNA in uterine endometrium during the menstrual cycle.
    Fujimoto J; Hori M; Ichigo S; Tamaya T
    Gynecol Endocrinol; 1996 Jun; 10(3):193-7. PubMed ID: 8862495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene.
    Barclay C; Li AW; Geldenhuys L; Baguma-Nibasheka M; Porter GA; Veugelers PJ; Murphy PR; Casson AG
    Clin Cancer Res; 2005 Nov; 11(21):7683-91. PubMed ID: 16278388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of fos and jun proto-oncogenes in benign versus malignant human uterine tissue.
    Nephew KP; Choi CM; Polek TC; McBride R; Bigsby RM; Khan SA; Husseinzadeh N
    Gynecol Oncol; 2000 Mar; 76(3):388-96. PubMed ID: 10684716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of basic fibroblast growth factor and its mRNA in advanced uterine cervical cancers.
    Fujimoto J; Ichigo S; Hori M; Hirose R; Sakaguchi H; Tamaya T
    Cancer Lett; 1997 Jan; 111(1-2):21-6. PubMed ID: 9022124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study on expression of plasminogen activator inhibitor 1 and its mRNA in endometrial cancers and normal endometria.
    Fujimoto J; Hori M; Ichigo S; Hirose R; Sakaguchi H; Tamaya T
    Tumour Biol; 1997; 18(1):13-21. PubMed ID: 8989921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.
    Soufla G; Sifakis S; Spandidos DA
    Cancer Lett; 2008 Feb; 259(2):146-55. PubMed ID: 18006148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of basic fibroblast growth factor and its mRNA in advanced ovarian cancers.
    Fujimoto J; Ichigo S; Hori M; Hirose R; Sakaguchi H; Tamaya T
    Eur J Gynaecol Oncol; 1997; 18(5):349-52. PubMed ID: 9378151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor.
    Hasegawa K; Ohashi Y; Ishikawa K; Yasue A; Kato R; Achiwa Y; Nishio E; Udagawa Y
    Int J Oncol; 2005 May; 26(5):1419-28. PubMed ID: 15809736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased expression of early growth response-1 and its role in uterine leiomyoma growth.
    Shozu M; Murakami K; Segawa T; Kasai T; Ishikawa H; Shinohara K; Okada M; Inoue M
    Cancer Res; 2004 Jul; 64(13):4677-84. PubMed ID: 15231681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of basic fibroblastic growth factor and microvessel density in endometrial carcinoma].
    Bai X; Mi R
    Zhonghua Fu Chan Ke Za Zhi; 2000 Jun; 35(6):348-51. PubMed ID: 11776176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas.
    Segawa T; Sasagawa T; Saijoh K; Inoue M
    Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
    Lord RV; Park JM; Wickramasinghe K; DeMeester SR; Oberg S; Salonga D; Singer J; Peters JH; Danenberg KD; Demeester TR; Danenberg PV
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):246-53. PubMed ID: 12579092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiogenic profile of uveal melanoma.
    Notting IC; Missotten GS; Sijmons B; Boonman ZF; Keunen JE; van der Pluijm G
    Curr Eye Res; 2006 Sep; 31(9):775-85. PubMed ID: 16966150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional regulation of beta1 integrin expression in the physio/pathological states of human endometrial tissues.
    Moro L; Greco M; Maiorano E; Selvaggi L; Marra E; Perlino E
    Int J Oncol; 2005 Feb; 26(2):457-65. PubMed ID: 15645131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased lymphatic vascular density is seen before colorectal cancers reach stage II and growth factor FGF-2 is downregulated in tumor tissue compared with normal mucosa.
    Sundlisaeter E; Røsland GV; Hertel JK; Sakariassen PØ; Almås B; Dicko A; Søndenaa K
    APMIS; 2009 Mar; 117(3):212-21. PubMed ID: 19245594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intermediate-conductance-Ca2+-activated K+ channels are overexpressed in endometrial cancer and involved in regulating proliferation of endometrial cancer cells].
    Wang ZH; Feng YJ; Su M; Yi XF
    Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):111-5. PubMed ID: 17442186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical staging for patients presenting with grade 1 endometrial carcinoma.
    Ben-Shachar I; Pavelka J; Cohn DE; Copeland LJ; Ramirez N; Manolitsas T; Fowler JM
    Obstet Gynecol; 2005 Mar; 105(3):487-93. PubMed ID: 15738013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant expression and mutations of TGF-beta receptor type II gene in endometrial cancer.
    Sakaguchi J; Kyo S; Kanaya T; Maida Y; Hashimoto M; Nakamura M; Yamada K; Inoue M
    Gynecol Oncol; 2005 Sep; 98(3):427-33. PubMed ID: 15993480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.